Oramed Pharmaceuticals Inc. engages in the research and development of pharmaceutical solutions forthe treatment of diabetes and for the use of orally ingestible capsules or pills for delivery of polypeptides. Its flagship product is the ORMD-0801, an oral ingestible insulin capsule. It is also developing an oral glucagon-like peptide-1 capsule.
